Matthew Emmens Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Matthew Emmens.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Matthew Emmens. Matthew Emmens is Director in BRISTOL MYERS SQUIBB CO ($BMY) and Director in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and President in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and President & CEO in VERTEX PHARMACEUTICALS INC / MA ($VRTX).
Latest Insider Trading Transactions of Matthew Emmens
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 03 2021 | BMY | BRISTOL MYERS SQUI ... | Emmens Matthew | Director | Option Exercise | A | 0.00 | 3,054 | 0 | 26,425 | |
| Jan 05 2021 | BMY | BRISTOL MYERS SQUI ... | Emmens Matthew | Director | Option Exercise | A | 0.00 | 584 | 0 | 23,188 | |
| Jul 02 2020 | BMY | BRISTOL MYERS SQUI ... | Emmens Matthew | Director | Option Exercise | A | 0.00 | 616 | 0 | 21,668 | |
| Apr 02 2020 | BMY | BRISTOL MYERS SQUI ... | Emmens Matthew | Director | Option Exercise | A | 0.00 | 650 | 0 | 20,895 | |
| Apr 02 2020 | BMY | BRISTOL MYERS SQUI ... | Emmens Matthew | Director | Option Exercise | A | 0.00 | 650 | 0 | 20,895 | |
| Jan 03 2020 | BMY | BRISTOL MYERS SQUI ... | Emmens Matthew | Director | Option Exercise | A | 0.00 | 565 | 0 | 17,105 | |
| Oct 02 2019 | BMY | BRISTOL MYERS SQUI ... | Emmens Matthew | Director | Option Exercise | A | 0.00 | 715 | 0 | 16,423 | |
| Oct 02 2019 | BMY | BRISTOL MYERS SQUI ... | Emmens Matthew | Director | Option Exercise | A | 0.00 | 715 | 0 | 16,423 | |
| Jul 02 2019 | BMY | BRISTOL MYERS SQUI ... | Emmens Matthew | Director | Option Exercise | A | 0.00 | 768 | 0 | 15,567 | |
| Apr 02 2019 | BMY | BRISTOL MYERS SQUI ... | Emmens Matthew | Director | Option Exercise | A | 0.00 | 681 | 0 | 14,670 | |
| Feb 05 2019 | BMY | BRISTOL MYERS SQUI ... | Emmens Matthew | Director | Option Exercise | A | 0.00 | 3,708 | 0 | 13,989 | |
| Feb 05 2019 | BMY | BRISTOL MYERS SQUI ... | Emmens Matthew | Director | Option Exercise | A | 0.00 | 3,708 | 0 | 13,989 | |
| Jan 03 2019 | BMY | BRISTOL MYERS SQUI ... | Emmens Matthew | Director | Option Exercise | A | 0.00 | 625 | 0 | 10,064 | |
| Oct 02 2018 | BMY | BRISTOL MYERS SQUI ... | Emmens Matthew | Director | Option Exercise | A | 0.00 | 524 | 0 | 9,439 | |
| Jul 03 2018 | BMY | BRISTOL MYERS SQUI ... | Emmens Matthew | Director | Option Exercise | A | 0.00 | 587 | 0 | 8,915 | |
| Jul 03 2018 | BMY | BRISTOL MYERS SQUI ... | Emmens Matthew | Director | Option Exercise | A | 0.00 | 587 | 0 | 8,915 | |
| Apr 03 2018 | BMY | BRISTOL MYERS SQUI ... | Emmens Matthew | Director | Option Exercise | A | 0.00 | 514 | 0 | 8,265 | |
| Apr 03 2018 | BMY | BRISTOL MYERS SQUI ... | Emmens Matthew | Director | Option Exercise | A | 0.00 | 514 | 0 | 8,265 | |
| Feb 05 2018 | BMY | BRISTOL MYERS SQUI ... | Emmens Matthew | Director | Option Exercise | A | 0.00 | 2,946 | 0 | 7,752 | |
| Apr 04 2017 | BMY | BRISTOL MYERS SQUI ... | Emmens Matthew | Director | Option Exercise | A | 0.00 | 199 | 0 | 3,124 | |
| Feb 23 2017 | BMY | BRISTOL MYERS SQUI ... | Emmens Matthew | Director | Option Exercise | A | 0.00 | 2,925 | 0 | 2,925 | |
| Feb 07 2011 | VRTX | VERTEX PHARMACEUTI ... | Emmens Matthew | President & CEO | Option Exercise | A | 38.80 | 236,000 | 9,156,800 | 236,000 | |
| Feb 07 2011 | VRTX | VERTEX PHARMACEUTI ... | Emmens Matthew | President & CEO | Grant | A | 0.01 | 47,201 | 472 | 229,406 | 182.2 K to 229.4 K (+25.91 %) |
| Jul 16 2010 | VRTX | VERTEX PHARMACEUTI ... | Emmens Matthew | President & CEO | Option Exercise | A | 33.82 | 118,000 | 3,990,760 | 118,000 | |
| Feb 08 2010 | VRTX | VERTEX PHARMACEUTI ... | Emmens Matthew | President & CEO | Option Exercise | A | 39.05 | 354,000 | 13,823,700 | 354,000 | |
| Feb 08 2010 | VRTX | VERTEX PHARMACEUTI ... | Emmens Matthew | President & CEO | Grant | A | 0.01 | 47,201 | 472 | 182,205 | 135 K to 182.2 K (+34.96 %) |
| Feb 06 2009 | VRTX | VERTEX PHARMACEUTI ... | Emmens Matthew | President | Option Exercise | A | 33.55 | 549,000 | 18,418,950 | 549,000 | |
| Feb 06 2009 | VRTX | VERTEX PHARMACEUTI ... | Emmens Matthew | President | Grant | A | 0.01 | 134,129 | 1,341 | 134,129 | 0 to 134.1 K |
| Jun 02 2008 | VRTX | VERTEX PHARMACEUTI ... | Emmens Matthew | Director | Option Exercise | A | 28.40 | 20,000 | 568,000 | 20,000 | |
| Jun 04 2007 | VRTX | VERTEX PHARMACEUTI ... | Emmens Matthew | Director | Option Exercise | A | 29.84 | 20,000 | 596,800 | 20,000 | |
| Jun 02 2006 | VRTX | VERTEX PHARMACEUTI ... | Emmens Matthew | Director | Option Exercise | A | 34.32 | 20,000 | 686,400 | 50,000 | |
| Jun 03 2005 | VRTX | VERTEX PHARMACEUTI ... | Emmens Matthew | Director | Option Exercise | A | 13.32 | 10,000 | 133,200 | 30,000 |
Page: 1